Latest Earnings Results: Q3 '26
Estimated EPS
-$0.35
Reported EPS
---
Surprise
---
Estimated Rev
$72.7M
Reported Rev
$76.38M
Surprise
+5.07%
$MED Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.28 down -221.74% YoY • Reported revenue of $76.38M down -27.64% YoY • Medifast expects third quarter 2026 revenue of $60 million to $80 million, with a loss per share of $0.15 to $0.65, and full year 2026 revenue of $270 million to $300 million.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.35 | -- | -- | N/A |
Q2 '26 | -$0.65 | -- | -- | N/A |
Q1 '26 | -$0.52 | -$0.19 | 63.46% | BEAT |
Q4 '25 | -$0.82 | -$0.55 | 32.93% | BEAT |
Q3 '25 | -$0.36 | -$0.21 | 41.67% | BEAT |